Monday Lunch Live
Improving cancer outcomes for culturally and linguistically diverse (CALD) communities
8 July 2024
The first of a three-part series, join us as we showcase the activities undertaken by the VCCC Alliance Health Equity Program during the Strategic Program Plan, to improve access to cancer care and services with consumers, researchers and clinicians.
The inaugural VCCC Alliance Health Equity Program was established as part of the VCCC Alliance Strategic Program Plan 2021-2024. One of the program activities is to improve cancer outcomes among culturally and linguistically diverse communities by understanding how health services can adopt and/or generate evidence to ensure cancer care, clinical trials and research will address the cultural and language needs of this priority group. Co-designing research projects involving appropriate community members to further interrogate the issues has been the forefront of all these activities to ensure better equitable cancer care.
This MLL is the first of a three-part series on the VCCC Alliance Health Equity Program.
Chair
Dr Beverley Woon
Consultant Radiologist and Carer, Peter MacCallum Cancer Centre, St Vincent's BreastScreen, and Eastern Health
Dr Beverley Woon was a member of the inaugural VCCC Alliance Equity Advisory Group and believes that our health industry is a reflection of our broader social views. Therefore, sustainable positive change can be reached when both culture and governance are addressed together. She is a collaborative researcher, with current research projects in Health Equity. Dr Woon is passionate about her clinical work and teaching, and is also an Honorary Clinical Lecturer at the University of Melbourne and an RANZCR examiner.
Speakers
Dr Umbreen Hafeez
Medical Oncologist and Clinician Researcher, Olivia Newton-John Cancer Wellness and Research Centre, Austin Health; Deputy Clinical Director, North Eastern Melbourne Integrated Cancer Services
Dr Hafeez's translational research focuses on developing and characterising novel anti-ErbB3 antibodies to combat cancer. She is also passionate about patient-centred care and committed to promoting and enhancing high-quality cancer care. She is a strong supporter of health equity, advocating for equal access to healthcare, treatment outcomes, and opportunities for all individuals, regardless of their background.
Ms Nicola Creagh
PhD Student and Research Assistant, Evaluation and Implementation Science Unit, Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne
Nicola is an early career researcher who’s work in evaluation and implementation science largely focuses on increasing equity and participation in Australia's national cancer screening programs. Nicola is passionate about equity in health and feels privileged to contribute to the work of ensuring systems are accessible, inclusive and support positive experiences for everyone in the prevention of cancer.
Dr Alesha Thai
Medical Oncologist and clinician-researcher, Austin Health and Peter MacCallum Cancer Centre
Dr Thai is an early-career clinician scientist focused on head and neck cancer, with particular interest in a nasopharyngeal carcinoma. It predominantly affects people from culturally and linguistically diverse backgrounds (CALD). Dr Thai is committed to addressing issues contributing to inequitable health care and is driven by her lived experiences as a second-generation immigrant, as well as her clinical work managing patients with head and neck cancer. Head and neck cancer can often affect patients who are from lower socioeconomic or CALD groups. She feels strongly that broad and concerted efforts are required to address the complex issues contributing to health inequity including recognising institutional structures that perpetuate inequity.
Resource details
This course is brought to you by
